PedAM
Pediatric Disease Annotations & Medicines
| Disease | mental depression |
| Phenotype | C0030567|parkinson\'s disease |
| Sentences | 82 |
| PubMedID- 22496988 | depression in parkinson's disease (pd) is frequently associated with executive deficits, which can influence nonliteral comprehension and lexical access. |
| PubMedID- 25873910 | Rational pharmacological approaches for cognitive dysfunction and depression in parkinson's disease. |
| PubMedID- 23271848 | Frequency of cognitive impairment and depression in parkinson's disease: a preliminary case-control study. |
| PubMedID- 25206565 | A previous study using diffusion tensor imaging demonstrated that while depression associated with parkinson's disease was associated with reduced numbers of amygdala-related white-matter fibers[54], dementia associated with parkinson's disease was primarily associated with reduced numbers of white matter in the temporal lobe and hippocampus[55]. |
| PubMedID- 21319866 | The role of dopamine agonists in the treatment of depression in patients with parkinson's disease: a systematic review. |
| PubMedID- 24622217 | The distinguishing feature of depression in patients with parkinson's disease is that guilt, self-blame and suicidal ideation are rarely seen compared to that observed in patients with major depression. |
| PubMedID- 25478095 | It is well known that the depression in parkinson's disease is helped by electroconvulsive treatment, but it is less appreciated that the motor symptoms of parkinson is also ameliorated.6,7 fromm published in 1959 the first report on the positive electroconvulsive treatment (ect) on parkinson's disease.8 aarsland et al from norway published positive results of maintenance ect in parkinson.9 the apathy seen in patients with parkinson's disease may very well be an expression of undetected depression.10 even mania in parkinson's disease has been successfully treated with ect.11 the positive effect on motor symptoms may develop before the effect on the mania using bitemporal stimulation. |
| PubMedID- 21614432 | Sleep disturbances were measured using the epworth sleepiness scale (ess) and the pittsburgh sleep quality index (psqi); qol with the parkinson's disease quality of life questionnaire (pdq-39); depression and anxiety with the hospital anxiety and depression scale (hads) and disease severity with the unified parkinson's disease rating scale (updrs). |
| PubMedID- 23448761 | Objective: to investigate the prevalence and clinical correlates of anxiety and depression in patients with parkinson's disease (pd) and to examine the relationship between anxiety and depression and the quality of life (qol). |
| PubMedID- 24461565 | Background: postural instability (pi) in parkinson's disease (pd) is associated with depression and apathy based on updrs scores. |
| PubMedID- 24803732 | Similarly, to further support this hypothesis, depression in parkinson's disease, huntington's disease, and epilepsy is correlated with reduced metabolic activity in the orbitofrontal cortex and caudate nucleus [19, 20]. |
| PubMedID- 24098546 | Methods: we conducted a network meta-analysis of randomized controlled trials to compare the efficacy and acceptability of therapeutic methods for the treatment of depression in parkinson's disease. |
| PubMedID- 22409644 | Predictors of treatment response to cognitive-behavioral therapy for depression in parkinson's disease. |
| PubMedID- 23316679 | Use of antidepressants for depression in patients with parkinson's disease. |
| PubMedID- 25509363 | This review focuses on the epidemiology, pathophysiology and different treatment modalities of depression in parkinson's disease. |
| PubMedID- 21969043 | A new (old) treatment option for depression in parkinson's disease. |
| PubMedID- 21676990 | Objective: despite the negative effects of depression in parkinson's disease, there is currently no evidence-based standard of care. |
| PubMedID- 22875323 | depression in parkinson's disease: diagnosis and management. |
| PubMedID- 20169775 | depression in parkinson's disease. |
| PubMedID- 26253340 | The purpose of our study was to assess the alteration of the brainstem raphe (br) on transcranial sonography (tcs) in depression patients with or without parkinson's disease (pd) and to explore whether the different changes of br could reflect an increasing impairment of raphe structures. |
| PubMedID- 19852008 | Objective: the prevalence rate of depression among patients with parkinson's disease (pd) has been estimated at 25%, although prevalence figures range between 7-76%. |
| PubMedID- 20565960 | Background: selective serotonin reuptake inhibitors (ssris) are the most commonly prescribed antidepressants for the treatment of depression in patients with parkinson's disease (pd) but data on their efficacy are controversial. |
| PubMedID- 20452823 | Background: depression is common in patients with parkinson's disease, but evidence on the efficacy of antidepressants in this population is lacking. |
| PubMedID- 21794923 | Is depression in parkinson's disease (pd) a specific entity. |
| PubMedID- 20694938 | Various approaches--be it medication, electroconvulsive therapy (ect), psychoeducation and psychotherapy--have also been developed to treat depression in patients with parkinson's disease. |
| PubMedID- 24218528 | Rivastigmine in apathetic but dementia and depression-free patients with parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial. |
| PubMedID- 24558835 | Objective: to study the effect of bushen huoxue herbs on depression of patients with parkinson's disease. |
| PubMedID- 20488273 | Assessment of depression in parkinson's disease: the contribution of somatic symptoms to the clinimetric performance of the hamilton and montgomery-asberg rating scales. |
| PubMedID- 24860212 | The presence and severity of depression in parkinson's disease has been shown to correlate significantly with health related quality-of-life scores. |
| PubMedID- 22992542 | Apathy is a valid behavioural syndrome in parkinson's disease and is associated with depression and cognitive deficits. |
| PubMedID- 25469455 | Conclusions: pain interference, pain severity, and pain disability is greater among parkinson's disease patients with anxiety and depression, in comparison to parkinson's disease patients without anxiety and depression. |
| PubMedID- 19950403 | Anxiety has been less extensively studied than depression in parkinson's disease (pd). |
| PubMedID- 22834671 | What is a rational antidepressant treatment for major depression in patients with parkinson's disease. |
| PubMedID- 20942300 | It is unknown, how frequently parkinson's disease (pd) is complicated by dementia, depression and other neuropsychiatric conditions. |
| PubMedID- 23301468 | Methods: sixty cases of parkinson's disease combined with depression were randomized into an acupuncture + medication group and a medication group, 30 cases in each one. |
| PubMedID- 21766001 | The role of cognitive-behavioural therapy for patients with depression in parkinson's disease. |
| PubMedID- 20708340 | Bupropion as the treatment of choice in depression associated with parkinson's disease and it's various treatments. |
| PubMedID- 20740485 | The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in parkinson's disease: a randomized, double-blind, placebo-controlled study. |
| PubMedID- 21764079 | Assessment methods and factors associated with depression in parkinson's disease. |
| PubMedID- 20014057 | The prevalence of depression in parkinson's disease (pd) varies greatly. |
| PubMedID- 21994070 | The present imaging study suggests that abnormalities in serotonin 1a receptor neurotransmission in the limbic system may be involved in the neural mechanisms underlying depression in patients with parkinson's disease. |
| PubMedID- 22857990 | White matter lesions and depression in patients with parkinson's disease. |
| PubMedID- 25385451 | The relation of sexual dysfunction to depression and anxiety in patients with parkinson's disease. |
| PubMedID- 25545969 | Abnormal functional connectivity of the amygdala is associated with depression in parkinson's disease. |
| PubMedID- 23114037 | Major life events and development of major depression in parkinson's disease patients. |
| PubMedID- 22708601 | Cognitive dysfunction and depression in parkinson's disease: what can be learned from rodent models. |
| PubMedID- 22300470 | Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in parkinson's disease. |
| PubMedID- 20740486 | Repetitive transcranial magnetic stimulation as treatment for depression in parkinson's disease. |
| PubMedID- 23346517 | depression in parkinson's disease is demonstrably different from ordinary major depression in terms of gender ratio, age, symptom profile, comorbidity, and chronicity. |
| PubMedID- 25377773 | depression in parkinson's disease: the effectiveness and risk of pharmacotherapy. |
Page: 1 2